Renegotiated pact could bolster OpenAI’s IPO ambitions and new AI tie-ups
Mankind Pharma bets on humour as antacid brand crosses Rs 200 crore.
Executive to lead next growth phase after Rs 1,000 crore disbursals.
Limited edition anime inspired supplements blend fandom with fitness culture.
Former Associate Director steps up after leading programmatic innovation